Archives
-
GPR30 in Spinal CCK+ Neurons Drives Neuropathic Pain Circuit
2026-06-10
This study demonstrates that the G protein-coupled estrogen receptor GPR30 is upregulated in spinal cholecystokinin-positive (CCK+) neurons after nerve injury, playing a pivotal role in neuropathic pain. Inhibiting GPR30 in these neurons reverses pain hypersensitivity, identifying GPR30 as a key mechanistic target for modulating neuropathic pain.
-
LACTB-Mediated Mitochondrial Remodeling Drives Apoptosis
2026-06-10
Kamerkar et al. reveal that the tumor suppressor LACTB directly remodels the inner mitochondrial membrane to facilitate cytochrome c release and apoptosis, independent of canonical BAX/BAK activity. These findings establish a new layer of mitochondrial apoptotic regulation, with relevance for cancer biology and apoptosis research.
-
Anti-Diabetic Drugs and Fracture Risk: Network Meta-Analysis
2026-06-09
This systematic review and network meta-analysis rigorously compares the effects of major anti-diabetic drugs, including SGLT2 inhibitors, on fracture risk in type 2 diabetes mellitus (T2DM) patients. The findings clarify that, while certain drugs like trelagliptin elevate fracture risk and others like voglibose reduce it, most anti-diabetic agents—including ertugliflozin—exert no statistically significant impact on fracture incidence.
-
Single-Cell Analysis Reveals BCL-2 as a Therapeutic Target i
2026-06-09
This study reveals that BCL-2 is upregulated in multiple prostate cancer cell subtypes following androgen receptor pathway inhibition, including by enzalutamide. Through single-cell imaging, preclinical modeling, and a Phase Ib trial, the work establishes BCL-2 as a shared vulnerability in heterogeneous castration-resistant prostate cancer, guiding future therapy strategies.
-
Rhodamine B as a Fluorescent Probe for Pesticide Drift Analy
2026-06-08
Rhodamine B (Basic Violet 10) shines in environmental and cell biology workflows as a high-sensitivity fluorescent probe. This article breaks down its applied use in UAV pesticide drift studies, protocol optimization, and troubleshooting strategies that empower researchers to achieve reproducible and quantitative fluorescent results.
-
Affinity-Purified Goat Anti-Rabbit IgG (H+L): Precision in I
2026-06-08
Unlock unmatched sensitivity in Western blot, ELISA, and IHC with the Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody. This APExBIO reagent delivers robust signal amplification, exceptional specificity, and seamless workflow integration for complex immunoassays.
-
Mapping Subcellular RNA-Binding Proteins via Functional Prox
2026-06-07
This study introduces APEX-PS, a method that unifies peroxidase-catalyzed proximity labeling with phase separation to map RNA-binding proteins (RBPs) in specific subcellular compartments. Application of APEX-PS revealed distinct RBP populations and identified SYNJ2BP as a mitochondrial mRNA anchor critical for stress recovery, offering new insight into spatially resolved protein function.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow
2026-06-06
The HRP Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive and specific detection of rabbit primary antibodies in immunoassays, including Western blot, ELISA, and IHC. It should not be used for diagnostic or clinical purposes and requires careful handling to maintain stability and performance.
-
Dissecting Drug Responses in Cancer: Insights from In Vitro
2026-06-05
Schwartz's dissertation introduces a systematic approach to disentangle proliferative arrest and cell death in cancer drug response assays. By clarifying the differences between relative and fractional viability, the study offers more accurate tools for evaluating anti-cancer agents, informing both preclinical research design and interpretation.
-
Ectomesenchymal Stem Cells Modulate Microglia After Brain He
2026-06-05
This study demonstrates that transplantation of ectomesenchymal stem cells (EMSCs) from nasal mucosa promotes microglial polarization toward an anti-inflammatory phenotype and increases IL-10 secretion after intracerebral hemorrhage (ICH) in mice. By inhibiting microglial NF-κB and MAPK signaling, EMSCs mitigate neuroinflammation and neuronal injury, suggesting a promising therapeutic avenue for hemorrhagic stroke recovery.
-
Cy3 TSA Fluorescence System Kit: High-Sensitivity Detection
2026-06-04
The Cy3 TSA Fluorescence System Kit enables ultrasensitive signal amplification in immunohistochemistry and related assays. This TSA fluorescence kit leverages HRP-catalyzed tyramide deposition to detect low-abundance biomolecules with robust fluorescence microscopy detection.
-
Trelagliptin Succinate Improves Insulin Signaling in Adipocy
2026-06-04
This study demonstrates that trelagliptin succinate enhances insulin sensitivity in adipocytes by activating the PI-3K/AKT/GLUT4 signaling pathway and modulating adipokine secretion. These findings clarify the molecular basis of trelagliptin’s anti-diabetic effects and offer experimental guidance for phosphorylation-focused metabolic research.
-
SAR405: Precision Vps34 Inhibitor for Autophagy Research
2026-06-03
SAR405, a nanomolar-potency Vps34 inhibitor from APExBIO, empowers researchers to dissect autophagy inhibition and vesicle trafficking with unmatched specificity. This guide translates recent mechanistic insights and validated protocols into actionable workflows, troubleshooting tips, and advanced applications for cancer and lysosomal disease models.
-
Doxorubicin Experimental Workflows in Cancer Cell Assays
2026-06-03
Doxorubicin (Adriamycin) is a cornerstone chemotherapeutic agent for solid tumors and hematologic malignancy research, renowned for its dual DNA intercalating and topoisomerase II inhibitory activity. This guide delivers actionable workflows, troubleshooting tips, and the latest innovations for maximizing reproducibility and data quality using APExBIO’s Doxorubicin.
-
LGI1 Synaptic Translocation Regulates Glutamatergic Transmis
2026-06-02
Cuhadar et al. (2024) reveal that LGI1 is dynamically translocated to the presynaptic membrane in response to neuronal activity, where its surface abundance tightly regulates glutamate release. These findings clarify LGI1’s mechanistic role in synaptic modulation and provide a framework for understanding its involvement in epilepsy and related disorders.